Tagadverse events

Monkeypox update: Vaccine appointments in SA / Clinical Guidance / Information for GBMSM / Podcast

M

1. Monkeypox Virus Vaccine in South Australia SHINE SA, 11th August 2022 The situation with monkeypox virus and vaccine availability is changing quickly. Limited monkeypox (MPX) vaccine appointments are now available in SA. As there is currently very limited supply of MPX Vaccine in SA, SHINE SA have been advised by SA Health that until further notice, eligibility is limited to people who meet...

Pelvic mesh implant patients want answers from Senate report

P

ABC 730 report, 26/3/2018 A steady stream of Australian women with pelvic mesh implants have spent tens of thousands of dollars flying to a clinic in Missouri to have their implants removed, claiming they have suffered major side-effects from the implants used to treat prolapse and incontinence. More than 35 Australian women have made the journey to the same practitioner because, they say, they...

SHINE SA Media Release: Response to the call to ban Diane-35

S

SHINE SA, issued 13th December 2017 SHINE SA believes everyone should have access to contraceptive choices, and that decisions about contraception are best made in conjunction with a healthcare professional. Cyproterone acetate pills, commonly known as Diane-35 appear to be associated with a higher risk of deep venous thrombosis (DVT) than levonorgestrel (LNG) containing pills, although the...

SHINE SA Media Release: Response to ABC report on Long Acting Reversible Contraception (LARCs)

S

SHINE SA, Issued: 13 December 2017 SHINE SA believes that decisions about contraception should be made in conjunction with a health care professional and that everyone should have access to accurate and unbiased information to enable appropriate informed contraceptive choice. LARCs (Long Acting Reversible Contraception) including the levonorgestrel IUD1 (Mirena) and the subdermal implant...

Safety of Medical Abortion Provided Through Telemedicine Compared With in Person

S

Obstetrics & Gynecology, September 05, 2017 doi: 10.1097/AOG.0000000000002212 ABSTRACT: OBJECTIVE: To compare the proportion of medical abortions with a clinically significant adverse event among telemedicine and in-person patients at a clinic system in Iowa during the first 7 years of the service. METHODS: We conducted a retrospective cohort study. We analyzed data on clinically significant...

Essure contraceptive device: Hazard Alert from TGA

E

Therapeutic Goods Administration, August 30, 2017
Consumers and health professionals are advised that Australasian Medical and Science Ltd (AMSL), in consultation with the TGA, has issued a hazard alert for Essure. AMSL is also recallingunused stock and withdrawing the device from the Australian market.

Read more of Essure contraceptive device: Hazard Alert

Your sidebar area is currently empty. Hurry up and add some widgets.